Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Phase II study of ICRF-159 (NSC-129943) in advanced colorectal carcinoma.

× No keyword cloud information.

7 in total

1. Adjuvant oral razoxane (ICRF-159) in resectable colorectal cancer.

Authors: J M Gilbert; K Hellmann; M Evans; P G Cassell; B Stoodley; H Ellis; C Wastell
Journal: Cancer Chemother Pharmacol Date: 1982 Impact factor: 3.333

2. Phase I clinical trial and pharmacokinetics of weekly ICRF-187 (NSC 169780) infusion in patients with solid tumors.

Authors: C L Vogel; E Gorowski; E Davila; M Eisenberger; J Kosinski; R P Agarwal; N Savaraj
Journal: Invest New Drugs Date: 1987 Impact factor: 3.850

3. Prospective randomised trial of early cytotoxic therapy for recurrent colorectal carcinoma detected by serum CEA.

Authors: K R Hine; P W Dykes
Journal: Gut Date: 1984-06 Impact factor: 23.059

4. Effect of razoxane on metastases from colorectal cancer.

Authors: K Hellmann; J Gilbert; M Evans; P Cassell; R Taylor
Journal: Clin Exp Metastasis Date: 1987 Jan-Mar Impact factor: 5.150

Review 5. Adjuvant treatment of colorectal cancer. Current status and concepts.

Authors: U F Metzger; B C Ghosh; D L Kisner
Journal: Cancer Chemother Pharmacol Date: 1985 Impact factor: 3.333

6. Prospective serial liver ultrasound scanning in resectable colorectal cancer treated with adjuvant razoxane.

Authors: R H Taylor; J M Gilbert; M G Evans; H G Lane; P G Cassell
Journal: Clin Exp Metastasis Date: 1984 Oct-Dec Impact factor: 5.150

7. Recent advances in cytotoxic therapy for gastrointestinal carcinoma: a review.

Authors: T J Priestman
Journal: J R Soc Med Date: 1978-03 Impact factor: 18.000

7 in total